Pierre Fabre Laboratories' BRAFTOVI (encorafenib) combination receives CHMP positive opinion in BRAFV600E-mutant mCRC

Menarini Group to present new elacestrant and tagraxofusp data at ASCO 2026 Annual Meeting

Hansa Biopharma's ConfIdeS Phase 3 trial abstract selected for ATC 2026

Dicot Pharma submits FDA application for LIB-01 phase 2b study

European Commission approves Pharming's Joenja for APDS treatment in the EU

Caliway Biopharmaceuticals receives US FDA IND clearance for second global Phase 3 study of CBL-514

AbbVie's MAVIRET receives positive opinion from European regulator

Enhertu recommended for EU approval in previously treated HER2 positive metastatic solid tumours

OSE Immunotherapeutics reports positive Phase 2 ovarian cancer trial results

INOVIO's oartner ApolloBio reports positive topline results from Phase 3 trial of VGX-3100

Allergan Aesthetics reports positive CHMP opinion recommending approval of Boey (trenibotulinumtoxinE)

Sobi reports positive topline results from Phase 3 study of pozdeutinurad in gout

Bayer's KERENDIA receives FDA priority review for type 1 diabetes and kidney disease treatment

Circio files new patent application for circVec gene therapy platform

BioMarin Pharmaceutical meets primary endpoint in Phase 3 study of VOXZOGO in children with hypochondroplasia